Equivalent price position
Unlock the full competitive price benchmark
See the exact peer median, min/max and quartiles, product rank, price percentile and the complete like-for-like competitor table.
Price-position comparison uses current official listed prices normalized to compatible units. It is a price benchmark, not a measure of sales, demand, prescription volume or market share.
Product details
- Generic
- Paclitaxel
- Therapeutic area
- Oncology & immunology
- Drug class
- Antineoplastic medicines
- ATC
- L01CD
- Strength
- 300 mg/50 mL
- Dosage form
- Concentrate for infusion
- Pack
- 1's
- Registration no.
- 114200
- Price record verified
- 2026-08-09
- Latest DRAP source check
- 2026-11-13 03:02
Manufacturer
Explore this manufacturer's complete MedInfoBase portfolio, generics and current listed prices.
View company portfolio →What Paclitaxel Concentrate (Paclitaxel) is used for
Paclitaxel is an anti-cancer (chemotherapy) medicine from the taxane group. It slows or stops the growth of cancer cells. It is given into a vein as a drip, in a hospital or clinic, by doctors and nurses. A specialist cancer doctor who is experienced in chemotherapy decides when it is used, and your cancer team plans your treatment and checks your blood tests.
- Ovarian cancer, for example after surgery (together with cisplatin) or if platinum medicines have not worked
- Breast cancer, including advanced or spreading breast cancer, and after surgery and other chemotherapy
- Advanced non-small-cell lung cancer, together with cisplatin, when surgery or radiotherapy is not suitable
- Kaposi's sarcoma in people with AIDS, when other treatments have not worked
- WHO's essential medicines list also names it for cancers of the nose and throat area (nasopharynx) and of the neck of the womb (cervix), as well as breast, ovary, lung and Kaposi sarcoma
Get medical help straight away if
- Tell your care team straight away, or get emergency help, for signs of a severe allergic reaction: hives, swelling of the face, lips, mouth, throat, hands or feet, chest tightness, trouble swallowing or breathing, or feeling faint. This can happen during the drip, and staff are watching for it.
- Get urgent help for a fever, severe chills, a sore throat, a cough or mouth ulcers. These can be signs of infection when your white blood cells are low.
- Get urgent help for unusual bruising or bleeding.
- Get urgent help for chest pain, a slow, fast or uneven heartbeat, or fainting.
Side effects, warnings and interactions for Paclitaxel
Prepared from the sources listed by the MedInfoBase team. General information, not medical advice: it gives no doses. Your doctor or pharmacist decides the medicine and dose for you.
About Paclitaxel Concentrate 300 mg/50 mL concentrate for infusion
Paclitaxel Concentrate 300 mg/50 mL concentrate for infusion contains Paclitaxel 300 mg/50 mL. It is registered with DRAP by Amgomed (registration no. 114200). Its official price is PKR 26,834.12 for a pack of 1's. This price has applied since 27 July 2026. Paclitaxel Concentrate is also available as 100 mg/16.7 mL concentrate for infusion and 30 mg/5 mL concentrate for infusion. 2 other brands of Paclitaxel 300 mg/50 mL (concentrate for infusion) are registered in Pakistan. Compare all brands and prices →
Other strengths of Paclitaxel Concentrate
All 2 other brands of Paclitaxel 300 mg/50 mL infusion in Pakistan
These 2 brands are alternatives (substitutes) to Paclitaxel Concentrate: each contains Paclitaxel 300 mg/50 mL infusion. Ask your doctor or pharmacist before you switch brands.
Sorted by price per unit, lowest first. The lowest is Biopac (Merixil Pharma) at PKR 37,532 per unit; the highest is Paclitaxel AqVida at PKR 39,461. All prices are official DRAP prices.
| Brand | Company | Pack | Official price | Per unit |
|---|---|---|---|---|
| Biopac | Merixil Pharma | 1's vial | PKR 37,531.84 | PKR 37,532 / unit |
| Paclitaxel AqVida | Himmel Pharmaceuticals Private Limited | 1's | PKR 39,460.98 | PKR 39,461 / unit |
Where to buy
MedInfoBase does not sell medicines and takes no orders. The company below holds the DRAP registration for Paclitaxel Concentrate, so it is the right place for a pharmacy, distributor or hospital buyer to ask about supply. A patient should buy from a licensed pharmacy.
- Registration holder
- Amgomed, Islamabad
- DRAP registration
- 114200
- Phone
- +92 51 2274145
- info@amgomed.org
- Website
- https://amgomed.org/
- Contact page
- Company contact page
Contact details as published by the company, last checked on 16 August 2026 (not yet independently verified). The price on this page is the official DRAP maximum retail price: a pharmacy may charge that or less, never more.
Official price over time
No change in the official DRAP price is recorded for this pack (1's). Current price PKR 26,834.12, effective 27 Jul 2026.
Cite this price history
MedInfoBase. Paclitaxel Concentrate 300 mg/50 mL, 1's: official price history (source: DRAP PharmaPrice Index). https://medinfobase.com/brand/paclitaxel-concentrate-300-mg-50-ml-114200-1s-amgomed/ (accessed 13 November 2026).
Official price history
| Amount | Effective from | Verified | Source | Status |
|---|---|---|---|---|
| PKR 26,834.12 | 2026-07-27 | 2026-08-09 | DRAP PharmaPrice Index | Current |
Cite this record
Medicine record · DRAP registration 114200Price and registration data on this page were observed on 9 August 2026. Records change over time, so please cite the observation date alongside the access date.